The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Open accessAbstract
As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute‐phase reactants, and serum biochemistry in COVID‐19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1‐week, self‐limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM‐, IgA‐, and IgG‐type virus‐specific antibodies levels are important measurements to predict population immunity against this disease and whether cross‐reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID‐19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine‐secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute‐phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Self-citationClinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Kidney disease is associated with in-hospital death of patients with COVID-19
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.005 · Cited by 2,941
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Coronavirus Infections—More Than Just the Common Cold
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020) · JAMA · doi:10.1001/jama.2020.0757 · Cited by 2,136
Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1643-8 · Cited by 2,031
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,911
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768
Self-citationLymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Tan, L., Wang, Q., Zhang, D., Ding, J., Huang, Q., Tang, Y.-Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,690
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa310 · Cited by 1,587
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,478
Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment
Fan, E., Brodie, D., & Slutsky, A. S. (2018) · JAMA · doi:10.1001/jama.2017.21907 · Cited by 1,470
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S.-Y. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,414
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Spread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Wu, P., Duan, F., Luo, C., Liu, Q., Qu, X., Liang, L., & Wu, K. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.1291 · Cited by 1,235
Conti, P. (2020) · Journal of Biological Regulators and Homeostatic Agents · doi:10.23812/conti-e · Cited by 1,227
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Han, H., Yang, L., Liu, R., Liu, F., Wu, K.-L., Li, J., Liu, X.-H., & Zhu, C.-L. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0188 · Cited by 1,223
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa150 · Cited by 1,131
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116
Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults
Xia, W., Shao, J., Guo, Y., Peng, X., Li, Z., & Hu, D. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24718 · Cited by 1,057
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Self-citationPhylogenetic network analysis of SARS-CoV-2 genomes
Forster, P., Forster, L., Renfrew, C., & Forster, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004999117 · Cited by 1,020
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 940
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L.-A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 903
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
Kim, Y.-I., Kim, S.-G., Kim, S.-M., Kim, E.-H., Park, S.-J., Yu, K.-M., Chang, J.-H., Kim, E. J., Lee, S., Casel, M. A. B., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.023 · Cited by 882
COVID-19 Autopsies, Oklahoma, USA
Barton, L. M., Duval, E. J., Stroberg, E., Ghosh, S., & Mukhopadhyay, S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa062 · Cited by 839
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
The cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y.-H., & Yang, Z.-Q. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 716
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000824 · Cited by 657
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Lippi, G., & Plebani, M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.004 · Cited by 652
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score
Ji, D., Zhang, D., Xu, J., Chen, Z., Yang, T., Zhao, P., Chen, G., Cheng, G., Wang, Y., Bi, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa414 · Cited by 630
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19
Qu, R., Ling, Y., Zhang, Y., Wei, L., Chen, X., Li, X., Liu, X., Liu, H., Guo, Z., Ren, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25767 · Cited by 580
Sun, D., Li, H., Lu, X.-X., Xiao, H., Ren, J., Zhang, F.-R., & Liu, Z.-S. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00354-4 · Cited by 577
Sun, P., Qie, S., Liu, Z., Ren, J., Li, K., & Xi, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25735 · Cited by 523
Autopsy in suspected COVID-19 cases
Hanley, B., Lucas, S. B., Youd, E., Swift, B., & Osborn, M. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206522 · Cited by 478
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Zhang, H., Zhou, P., Wei, Y., Yue, H., Wang, Y., Hu, M., Zhang, S., Cao, T., Yang, C., Li, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0533 · Cited by 474
Zhang, Y., Zheng, L., Liu, L., Zhao, M., Xiao, J., & Zhao, Q. (2020) · Liver International · doi:10.1111/liv.14455 · Cited by 471
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436
Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract
Renegar, K. B., Small, P. A., Boykins, L. G., & Wright, P. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1978 · Cited by 423
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Ulrich, H., & Pillat, M. M. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-09976-7 · Cited by 418
Li, X., Wang, L., Yan, S., Yang, F., Xiang, L., Zhu, J., Shen, B., & Gong, Z. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.053 · Cited by 402
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Ji, H.-L., Zhao, R., Matalon, S., & Matthay, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00013.2020 · Cited by 399
Ng, D. L., Al Hosani, F., Keating, M. K., Gerber, S. I., Jones, T. L., Metcalfe, M. G., Tong, S., Tao, Y., Alami, N. N., Haynes, L. M., et al. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.024 · Cited by 384
The intracellular sites of early replication and budding of SARS-coronavirus
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A., Weber, F., & Kochs, G. (2007) · Virology · doi:10.1016/j.virol.2006.11.027 · Cited by 382
Fung, S.-Y., Yuen, K.-S., Ye, Z.-W., Chan, C.-P., & Jin, D.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 381
The CD8 T Cell Response to Respiratory Virus Infections
Schmidt, M. E., & Varga, S. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00678 · Cited by 371
Management of Critically Ill Adults With COVID-19
Poston, J. T., Patel, B. K., & Davis, A. M. (2020) · JAMA · doi:10.1001/jama.2020.4914 · Cited by 367
CD4+CD25+ Regulatory T Cells Control the Severity of Viral Immunoinflammatory Lesions
Suvas, S., Azkur, A. K., Kim, B. S., Kumaraguru, U., & Rouse, B. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4123 · Cited by 358
Self-citationEosinophil responses during COVID-19 infections and coronavirus vaccination
Lindsley, A. W., Schwartz, J. T., & Rothenberg, M. E. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.021 · Cited by 354
Treatment for severe acute respiratory distress syndrome from COVID-19
Matthay, M. A., Aldrich, J. M., & Gotts, J. E. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30127-2 · Cited by 350
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y., Lu, X., Zhang, J., Du, H., Yan, Y., Akdis, C. A., & Gao, Y. (2020) · Allergy · doi:10.1111/all.14289 · Cited by 347
Self-citationMechanisms and treatment of allergic disease in the big picture of regulatory T cells
Akdis, C. A., & Akdis, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.030 · Cited by 337
Self-citationCOVID-19: faecal–oral transmission?
Hindson, J. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0295-7 · Cited by 332
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, O., Akdis, M., Martín‐Fontecha, M., & Akdis, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 330
Self-citationLiew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M., & Beale, J. (1984) · European Journal of Immunology · doi:10.1002/eji.1830140414 · Cited by 314
Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
Behrens, E. M., & Koretzky, G. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40071 · Cited by 304
Global Leprosy Status in 2020: Still Losing Touch
Franco-Paredes, C., Montes de Oca Sanchez, G., & White, C. (2020) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.2019252 · Cited by 294
Wang, K., Zuo, P., Liu, Y., Zhang, M., Zhao, X., Xie, S., Zhang, H., Chen, X., & Liu, C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa538 · Cited by 288
Treatment of COVID-19: old tricks for new challenges
Cunningham, A. C., Goh, H. P., & Koh, D. (2020) · Critical Care · doi:10.1186/s13054-020-2818-6 · Cited by 286
Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., & Jin, D.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008227 · Cited by 272
Goh, K. J., Choong, M. C., Cheong, E. H., Kalimuddin, S., Wen, S. D., Phua, G. C., Chan, K. S., & Mohideen, S. H. (2020) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.202057 · Cited by 264
Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation
Tam, V. C., Quehenberger, O., Oshansky, C. M., Suen, R., Armando, A. M., Treuting, P. M., Thomas, P. G., Dennis, E. A., & Aderem, A. (2013) · Cell · doi:10.1016/j.cell.2013.05.052 · Cited by 245
Xiong, L., Edwards, C., & Zhou, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017411 · Cited by 225
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Wang, J.-T., Sheng, W.-H., Fang, C.-T., Chen, Y.-C., Wang, J.-L., Yu, C.-J., Chang, S.-C., & Yang, P.-C. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030640 · Cited by 223
Tregs control the development of symptomatic West Nile virus infection in humans and mice
Lanteri, M. C., O’Brien, K. M., Purtha, W. E., Cameron, M. J., Lund, J. M., Owen, R. E., Heitman, J. W., Custer, B., Hirschkorn, D. F., Tobler, L. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39387 · Cited by 212
Can melatonin reduce the severity of COVID-19 pandemic?
Shneider, A., Kudriavtsev, A., & Vakhrusheva, A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1756284 · Cited by 185
The role of C5a in acute lung injury induced by highly pathogenic viral infections
Wang, R., Xiao, H., Guo, R., Li, Y., & Shen, B. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.28 · Cited by 170
Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination
Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019) · Journal of Clinical Virology · doi:10.1016/j.jcv.2019.08.009 · Cited by 168
COVID-19 – what should anaethesiologists and intensivists know about it?
Wujtewicz, M. A., Dylczyk-Sommer, A., Aszkiełowicz, A., Zdanowski, S., Piwowarczyk, S., & Owczuk, R. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.93756 · Cited by 160
See, R. H., Zakhartchouk, A. N., Petric, M., Lawrence, D. J., Mok, C. P. Y., Hogan, R. J., Rowe, T., Zitzow, L. A., Karunakaran, K. P., Hitt, M., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81579-0 · Cited by 153
Deftereos, S. G., Siasos, G., Γιαννόπουλος, Γ., Vrachatis, D. A., Angelidis, C., Giotaki, S. G., Gargalianos, P., Giamarellou, H., Gogos, C., Daikos, G. L., et al. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.03.002 · Cited by 148
The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches.
Gonzales, J. N., Lucas, R., & Verin, A. D. (2015) · PubMed · Cited by 142
Ko, J., Park, G. E., Lee, J. Y., Lee, J., Cho, S. Y., Ha, Y. E., Kang, C., Kang, J., Kim, Y., Huh, H. J., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.08.005 · Cited by 138
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
Lee, Y.-L., Liao, C.-H., Liu, P., Cheng, C., Chung, M., Liu, C.-E., Chang, S., & Hsueh, P. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.019 · Cited by 137
Li, Y., Chen, M., Cao, H., Zhu, Y., Zheng, J., & Zhou, H. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.10.008 · Cited by 127
Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
Zhang, H., Chen, Y., Yuan, Q., Xia, Q.-X., Zeng, X.-P., Peng, J.-T., Liu, J., Xiao, X., Jiang, G.-S., Xiao, H.-Y., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.03.030 · Cited by 125
Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm
Younan, P. M., Iampietro, M., Nishida, A., Ramanathan, P., Santos, R. I., Dutta, M., Lubaki, N. M., Koup, R. A., Katze, M. G., & Bukreyev, A. A. (2017) · mBio · doi:10.1128/mbio.00845-17 · Cited by 122
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
Bermejo-Martín, J. F., Almansa, R., Menéndez, R., Méndez, R., Kelvin, D. J., & Torres, A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.029 · Cited by 120
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Zhang, H., Wang, C., Zhou, P., Yue, H., & Du, R. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0895 · Cited by 117
Is BCG vaccination affecting the spread and severity of COVID‐19?
Özdemir, C., Küçüksezer, U. C., & Tamay, Z. (2020) · Allergy · doi:10.1111/all.14344 · Cited by 112
From SARS coronavirus to novel animal and human coronaviruses.
To, K. K., Hung, I. F., Chan, J. F., & Yuen, K. (2013) · Europe PMC (PubMed Central) · doi:10.3978/asvide.2014.121 · Cited by 107
Eosinophils and Respiratory Viruses
Flores-Torres, A. S., Salinas-Carmona, M. C., Salinas, E., & Rosas-Taraco, A. G. (2019) · Viral Immunology · doi:10.1089/vim.2018.0150 · Cited by 106
Cell-free hemoglobin: a novel mediator of acute lung injury
Shaver, C. M., Upchurch, C. P., Janz, D. R., Grove, B. S., Putz, N. D., Wickersham, N. E., Dikalov, S., Ware, L. B., & Bastarache, J. A. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00155.2015 · Cited by 99
Acute phase protein response to viral infection and vaccination
Pérez, L. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.07.013 · Cited by 86
Loebbermann, J., Durant, L. R., Thornton, H. V., Johansson, C., & Openshaw, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217580110 · Cited by 74
Fine Tuning the Cytokine Storm by IFN and IL-10 Following Neurotropic Coronavirus Encephalomyelitis
Savarin, C., & Bergmann, C. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03022 · Cited by 69
Kim, M. H., Kim, H. J., & Chang, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220196 · Cited by 69
[Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].
Li, Y., Wu, W., Yang, T., Zhou, W., Fu, Y. M., Feng, Q. M., & Ye, J. M. (2020) · PubMed · doi:10.3760/cma.j.cn112138-20200221-00114 · Cited by 67
Chen, R., Chang, J., Yeh, W.-T., Lee, C., Liu, J.-W., Eng, H.-L., & Yang, K. D. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.06.007 · Cited by 64
Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release
Eastwood, D., Bird, C., Dilger, P., Hockley, J., Findlay, L., Poole, S., Thorpe, S. J., Wadhwa, M., Thorpe, R., & Stebbings, R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12165 · Cited by 58
Tolerance mechanisms of allergen immunotherapy
van de Veen, W., & Akdiş, M. (2019) · Allergy · doi:10.1111/all.14126 · Cited by 48
Stability of regulatory T cells in T helper 2–biased allergic airway diseases
Lan, F., Zhang, N., Bachert, C., & Zhang, L. (2020) · Allergy · doi:10.1111/all.14257 · Cited by 46
High Anti–Dengue Virus Activity of theOASGene Family Is Associated With Increased Severity of Dengue
Simon‐Lorière, E., Lin, R.-J., Kalayanarooj, S. M., Chuansumrit, A., Casadémont, I., Lin, S.-Y., Yu, H.-P., Lert-itthiporn, W., Chaiyaratana, W., Tangthawornchaikul, N., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv321 · Cited by 43
Retamal-Díaz, A. R., Covián, C., Pacheco, G. A., Castiglione-Matamala, A. T., Bueno, S. M., González, P. A., & Kalergis, A. M. (2019) · Pathogens · doi:10.3390/pathogens8030147 · Cited by 29
SARS‐CoV‐2 immunogenicity at the crossroads
Karamloo, F., & König, R. (2020) · Allergy · doi:10.1111/all.14360 · Cited by 28
Sun, P., Ren, J., Li, K., Qie, S., Liu, Z., & Xi, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25818 · Cited by 24
Antibody responses and protection in mice immunized orally against influenza virus
TAKASE, H. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00128-4 · Cited by 18
Zhang, H., Sun, Y., Lin, Z., Yang, G., Liu, J., Mo, L., Geng, X., Song, Y., Zeng, H., Zhao, M., et al. (2019) · Allergy · doi:10.1111/all.14157 · Cited by 10
Herbinger, K., Hanus, I., Schunk, M., Beißner, M., von Sonnenburg, F., Löscher, T., Bretzel, G., Höelscher, M., Nothdurft, H. D., & Huber, K. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0387 · Cited by 7
Aksoy, E., & Azkur, A. K. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.18-0582 · Cited by 7
Self-citation
Cited by
The cytokine storm and COVID-19
Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Self-citationThe signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., et al. (2020) · Allergy · doi:10.1111/all.14429 · Cited by 543
Self-citationSystemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., Raeber, M. E., Adamo, S., Weigang, S., Emmenegger, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.040 · Cited by 408
Metadata
- Authors
- Azkur, A. K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K., & Akdis, C. A.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2020-07
- Volume
- 75
- Issue
- 7
- Pages
- 1564-1581
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W3024541652
- Cited by
- 1,119
- References
- 139
- FWCI
- 28.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.